Up a level |
Journal Article
Goeckeritz, Elisa, Kerwien, Susan, Baumann, Michael, Wigger, Marion, Vondey, Verena, Neumann, Lars, Landwehr, Thomas, Wendtner, Clemens M., Klein, Christian ORCID: 0000-0001-7594-7280, Liu, Ningshu, Hallek, Michael, Frenzel, Lukas P. and Krause, Guenter (2015). Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells. Int. J. Cancer, 137 (9). S. 2234 - 2243. HOBOKEN: WILEY-BLACKWELL. ISSN 1097-0215
Goeckeritz, Elisa, Vondey, Verena, Guastafierro, Anna, Pizevska, Maja, Hassenrueck, Floyd, Neumann, Lars, Hallek, Michael and Krause, Guenter (2017). Establishing a chemical genetic link between Bruton tyrosine kinase activity in malignant B cells and cell functions involved in the micro-environmental dialogue. Br. J. Haematol., 178 (6). S. 949 - 954. HOBOKEN: WILEY. ISSN 1365-2141
Hassenrueck, Floyd, Knoedgen, Eva, Goeckeritz, Elisa, Midda, Safi Hasan ORCID: 0000-0002-2822-6293, Vondey, Verena, Neumann, Lars, Herter, Sylvia, Klein, Christian ORCID: 0000-0001-7594-7280, Hallek, Michael and Krause, Guenter (2018). Sensitive Detection of the Natural Killer Cell-Mediated Cytotoxicity of Anti-CD20 Antibodies and Its Impairment by B-Cell Receptor Pathway Inhibitors. Biomed Res. Int., 2018. LONDON: HINDAWI LTD. ISSN 2314-6141
Krause, Guenter, Baki, Imaan, Kerwien, Susan, Knoedgen, Eva, Neumann, Lars, Goeckeritz, Elisa, Landwehr, Thomas, Heider, Karl-Heinz and Hallek, Michael (2016). Cytotoxicity of the CD37 antibody BI 836826 against chronic lymphocytic leukaemia cells in combination with chemotherapeutic agents or PI3K inhibitors. Br. J. Haematol., 173 (5). S. 791 - 795. HOBOKEN: WILEY-BLACKWELL. ISSN 1365-2141
Krause, Guenter, Hassenrueck, Floyd and Hallek, Michael (2020). Cell line-based assessment of BTK inhibitors. Br. J. Pharmacol., 177 (9). S. 2163 - 2166. HOBOKEN: WILEY. ISSN 1476-5381
Krause, Guenter, Hassenrueck, Floyd and Hallek, Michael (2018). Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib. Drug Des. Dev. Ther., 12. S. 2577 - 2591. ALBANY: DOVE MEDICAL PRESS LTD. ISSN 1177-8881
Krause, Guenter ORCID: 0000-0003-3905-0921, Hassenrueck, Floyd and Hallek, Michael (2020). Relevant Cytokines in the B Cell Lymphoma Micro-Environment. Cancers, 12 (9). BASEL: MDPI. ISSN 2072-6694